Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
3(75%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

4

all time

Status Distribution
Active(3)
Completed(1)

Detailed Status

Active, not recruiting3
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
3
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

active_not_recruiting375%
completed125%

Recent Activity

3 active trials
Showing 4 of 4
active_not_recruitingnot_applicable

A Clinical Study of the Paradise™ Renal Denervation System in Patients With Hypertension (RADIANCE-HTN DUO)

NCT05326230
active_not_recruitingnot_applicable

The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension

NCT03614260
active_not_recruitingnot_applicable

Prairie Loin Pain Hematuria Syndrome Renal Denervation Study: A Feasibility Study

NCT04332731
completednot_applicable

SYMPLICITY HTN-3 Renal Denervation in Patients With Uncontrolled Hypertension

NCT01418261

Clinical Trials (4)

Showing 4 of 4 trials
NCT05326230Not Applicable

A Clinical Study of the Paradise™ Renal Denervation System in Patients With Hypertension (RADIANCE-HTN DUO)

Active Not Recruiting
NCT03614260Not Applicable

The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension

Active Not Recruiting
NCT04332731Not Applicable

Prairie Loin Pain Hematuria Syndrome Renal Denervation Study: A Feasibility Study

Active Not Recruiting
NCT01418261Not Applicable

SYMPLICITY HTN-3 Renal Denervation in Patients With Uncontrolled Hypertension

Completed

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4